Greiz, Germany

Ralf Oettmeir

This inventor holds 1 USPTO granted patent. Top assignee: Medicur Pharma Gmbh. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ralf Oettmeir. Retrieved from https://idiyas.com/inventor/ralf-oettmeir

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ralf Oettmeir: Innovator in Inflammation Treatment

Introduction

Ralf Oettmeir is a notable inventor based in Greiz, Germany. He has made significant contributions to the field of medicine, particularly in the area of inflammation treatment. His innovative approach has led to the development of a patented method that aims to inhibit inflammation.

Latest Patents

Ralf Oettmeir holds 1 patent for his invention titled "Method for inhibiting inflammation." This patent reflects his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Oettmeir is currently associated with Medicur Pharma GmbH, where he continues to work on innovative solutions in the pharmaceutical industry. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Carsten Weber and Uwe Reuter. Their collective expertise enhances the innovative environment at Medicur Pharma GmbH.

Conclusion

Ralf Oettmeir's work in developing methods to inhibit inflammation showcases his dedication to medical innovation. His contributions are vital in the ongoing quest for effective treatments in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…